Elias Barbosa da Silva-Junior, Victor Guedes de Araujo, Carlla Assis Araujo-Silva, Luciana Polaco Covre, Joyce Cristina Guimarães de Oliveira, Israel Diniz-Lima, Leonardo Freire-de-Lima, Alexandre Morrot, Lycia de Brito-Gitirana, Jose Osvaldo Previato, Lucia Mendonça-Previato, Rossiane Claudia Vommaro, Hilda Petrs-Silva, Debora Decote-Ricardo, Herbert Leonel de Matos Guedes, Celio Geraldo Freire-de-Lima
{"title":"Lack of TLR9 exacerbates ocular impairment and visual loss during systemic Cryptococcus gattii infection","authors":"Elias Barbosa da Silva-Junior, Victor Guedes de Araujo, Carlla Assis Araujo-Silva, Luciana Polaco Covre, Joyce Cristina Guimarães de Oliveira, Israel Diniz-Lima, Leonardo Freire-de-Lima, Alexandre Morrot, Lycia de Brito-Gitirana, Jose Osvaldo Previato, Lucia Mendonça-Previato, Rossiane Claudia Vommaro, Hilda Petrs-Silva, Debora Decote-Ricardo, Herbert Leonel de Matos Guedes, Celio Geraldo Freire-de-Lima","doi":"10.1093/infdis/jiaf034","DOIUrl":null,"url":null,"abstract":"Cryptococcus gattii is a saprophytic basidiomycete that grows in the environment and can cause systemic cryptococcosis. Ocular cryptococcosis causes blindness and is commonly associated with central nervous system (CNS) infection. Toll-like receptor 9 (TLR9) can control cryptococcosis and another mycosis. Here, using C57BL/6 TLR9 knockout mice (TLR9-/-), we evaluated the role of TLR9 signaling in ocular involvement during systemic C. gattii-infection. We observed ocular impairment and found a high fungal burden in the retina, vitreous humor (VH), and optic nerve (ON) of TLR9-/- mice three weeks after infection. Capsular polysaccharide glucuronoxylomannan (GXM) deposition, astrogliosis and morphological alterations in retina lead to progressive blindness of TLR9-/- mice. The phenomenon observed in our work has not yet been explored in a murine model. These results contribute to the understanding of the role of TLR9 during ocular cryptococcosis. Therapies using TLR9 agonists may be important for the treatment of ocular cryptococcosis.","PeriodicalId":501010,"journal":{"name":"The Journal of Infectious Diseases","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/infdis/jiaf034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cryptococcus gattii is a saprophytic basidiomycete that grows in the environment and can cause systemic cryptococcosis. Ocular cryptococcosis causes blindness and is commonly associated with central nervous system (CNS) infection. Toll-like receptor 9 (TLR9) can control cryptococcosis and another mycosis. Here, using C57BL/6 TLR9 knockout mice (TLR9-/-), we evaluated the role of TLR9 signaling in ocular involvement during systemic C. gattii-infection. We observed ocular impairment and found a high fungal burden in the retina, vitreous humor (VH), and optic nerve (ON) of TLR9-/- mice three weeks after infection. Capsular polysaccharide glucuronoxylomannan (GXM) deposition, astrogliosis and morphological alterations in retina lead to progressive blindness of TLR9-/- mice. The phenomenon observed in our work has not yet been explored in a murine model. These results contribute to the understanding of the role of TLR9 during ocular cryptococcosis. Therapies using TLR9 agonists may be important for the treatment of ocular cryptococcosis.